Autologous hematopoietic stem cell transplantation in progressive severe multiple sclerosis
Multiple sclerosis (MS) is a chronic inflammatory disease of central nervous system (CNS), which is disabling and majorly involves younger population. Various available treatments in forms of immunomodulation are not very effective; however, stem cell transplantation seems to be promising in recent...
Main Authors: | Awadh Kishor Pandit, Kameshwar Prasad, Tulika Seth |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2015-01-01
|
Series: | Annals of Indian Academy of Neurology |
Subjects: | |
Online Access: | http://www.annalsofian.org/article.asp?issn=0972-2327;year=2015;volume=18;issue=4;spage=459;epage=463;aulast=Pandit |
Similar Items
-
CLINICAL EFFECTIVENESS OF HIGH-DOSE IMMUNOSUPPRESSIVE THERAPY WITH AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN MULTIPLE SCLEROSIS PATIENTS
by: D. A. Fedorenko, et al.
Published: (2014-12-01) -
Dynamics of Inflammatory and Neurodegenerative Biomarkers after Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis
by: Josefine Ruder, et al.
Published: (2022-09-01) -
Rituximab as a Treatment Option after Autologous Hematopoietic Stem Cell Transplantation in a Patient with Systemic Sclerosis
by: Paul Gressenberger, et al.
Published: (2021-06-01) -
COVID-19 infection in hematopoietic stem cell transplant recipients
by: Siniaev A.A., et al.
Published: (2022-09-01) -
Human NK Cells in Autologous Hematopoietic Stem Cell Transplantation for Cancer Treatment
by: Ane Orrantia, et al.
Published: (2021-03-01)